Ausper Biopharma Co., Ltd.

This large, late-stage study is testing whether a new injection called AHB-137 can help people with a specific type of chronic hepatitis B. The goal is to see if the injection can keep the virus under control even after participants stop taking their current daily antiviral pills…

This study is testing an investigational drug called AHB-137 in people with a specific type of chronic hepatitis B who are already taking standard antiviral pills. The main goal is to see if adding AHB-137 can further reduce the amount of virus in the blood and potentially allow …

This study is testing whether adding an experimental injection called AHB-137 to standard hepatitis B treatments can help patients eventually stop their daily antiviral pills. The research involves 127 adults with a specific type of chronic hepatitis B who are already taking anti…

This early-stage study is testing a new injectable drug called AHB-137 for people with chronic Hepatitis B. It first checks if the drug is safe in healthy volunteers, then gives it to Hepatitis B patients who are already on stable antiviral pills. The main goal is to see if addin…

This study is testing an experimental drug called AHB-137 in adults with chronic hepatitis B who have never received treatment. The main goal is to see if the drug can reduce the hepatitis B virus to very low or undetectable levels in the blood. Researchers will also monitor side…